JP Morgan Chase’s Boundless Bio BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.99K Buy
1,169
+990
+553% +$2.67K ﹤0.01% 7399
2026
Q2
$439 Buy
179
+10
+6% +$15 ﹤0.01% 7437
2026
Q1
$183 Hold
169
– – ﹤0.01% 7262
2025
Q4
$203 Buy
+169
New +$211 ﹤0.01% 7156
2025
Q3
– Sell
-1,127
Closed -$1.14K – 7777
2025
Q2
$1.14K Sell
1,127
-18,125
-94% -$24.1K ﹤0.01% 6609
2025
Q1
$29.1K Sell
19,252
-59,643
-76% -$124K ﹤0.01% 6039
2024
Q4
$229K Buy
78,895
+68,959
+694% +$201K ﹤0.01% 5421
2024
Q3
$34.5K Buy
9,936
+7,247
+270% +$26.3K ﹤0.01% 6102
2024
Q2
$10.4K Buy
+2,689
New +$25.7K ﹤0.01% 6256

Other funds holding BOLD

JP Morgan Chase's BOLD Position: Q3 2026 in Review

JP Morgan Chase increased its Boundless Bio (BOLD) stake by 553% in Q3 2026, buying an estimated $2.67K and bringing the position to 1,169 shares worth $2.99K. The position accounts for ﹤0.01% of the portfolio, ranked #7399.

JP Morgan Chase first reported a position in BOLD in Q2 2024 and has held it in 9 quarters since. The position peaked at $229K in Q4 2024. 42 funds tracked by Wall St. Rank hold BOLD as of Q3 2026.

  • JP Morgan Chase held 1,169 shares of Boundless Bio worth $2.99K as of Q3 2026.
  • JP Morgan Chase bought 990 Boundless Bio shares in Q3 2026, an estimated $2.67K.
  • Boundless Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7399 holding.
  • JP Morgan Chase first reported a position in Boundless Bio in Q2 2024 and has held it in 9 quarters since.
  • JP Morgan Chase's Boundless Bio position peaked at $229K in Q4 2024.
  • 42 funds tracked by Wall St. Rank held Boundless Bio as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.